Moderna has asked the FDA for an emergency authorization that would allow all adults to receive a second COVID-19 booster, the company announced on Thursday.
Why it matters: The request is likely to intensify an ongoing scientific debate over how long protection from the two most-used vaccines in the U.S. lasts in the face of new variants.